Premium
Bearing 19q13 aberration predicts poor prognosis in non‐germinal centre type of CD 5 + DLBCL
Author(s) -
Mishima Yuko,
Terui Yasuhito,
Yokoyama Masahiro,
Nishimura Noriko,
Ueda Kyoko,
Kusano Yoshiharu,
Yamauchi Hirofumi,
Inoue Norihito,
Takahashi Anna,
Tsuyama Naoko,
Mishima Yuji,
Takeuchi Kengo,
Hatake Kiyohiko
Publication year - 2018
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15001
Subject(s) - diffuse large b cell lymphoma , cd5 , rituximab , medicine , bcl6 , vincristine , lymphoma , international prognostic index , germinal center , cyclophosphamide , gastroenterology , oncology , chemotherapy , b cell , immunology , antibody